About CureMarkMediSciences
CureMarkMediSciences is a company based in India founded in 2020. It operates as a B2B and Distribution. CureMarkMediSciences offers products and services including Antipyretics & Anti-Inflammatory, Anti-Biotic & Antibacterial, Antacid & Anti-Ulcerant, Multivitamin & Hematinics, and Cardiac & Diabetic. CureMarkMediSciences operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cure Mark Medisciences Pvt. Ltd.
- Jurisdiction Hubli, Karnataka, India
-
Annual Revenue
$225.72 K (USD)7.73as on Mar 31, 2023
-
Net Profit
-$1.08 K (USD)-125.44as on Mar 31, 2023
-
EBITDA
$18.27 K (USD)-15.67as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CureMarkMediSciences
CureMarkMediSciences offers a comprehensive portfolio of products and services, including Antipyretics & Anti-Inflammatory, Anti-Biotic & Antibacterial, Antacid & Anti-Ulcerant, Multivitamin & Hematinics, and Cardiac & Diabetic.
Products for reducing fever and treating inflammation effectively.
Drugs to fight bacterial infections and promote health.
Treats acidity and ulcers for digestive health relief.
Nutritional products to support overall body health and vitality.
Medicines for managing heart conditions and diabetes control.
Funding Insights of CureMarkMediSciences
Detailed funding history for CureMarkMediSciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CureMarkMediSciences
Investment portfolio details for CureMarkMediSciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CureMarkMediSciences
Detailed financials for CureMarkMediSciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curemarkmedisciences Comparisons
Peer comparison for CureMarkMediSciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CureMarkMediSciences
CureMarkMediSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oral solid drug delivery systems are manufactured and developed.
|
|
| Locked | Locked | Locked |
Solid and semisolid dosage forms are developed and manufactured.
|
|
| Locked | Locked | Locked |
Company developing small molecules & eukaryotic cell based recombinant protein drugs
|
|
| Locked | Locked | Locked |
Dosage forms are delivered for preclinical, clinical, and commercial supply.
|
|
| Locked | Locked | Locked |
CDMO manufacturing solid drugs
|
|
| Locked | Locked | Locked |
Product development, manufacturing and packaging services
|
Detailed competitors of CureMarkMediSciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curemarkmedisciences
Complete news archive for CureMarkMediSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CureMarkMediSciences
CureMarkMediSciences was founded in 2020.
CureMarkMediSciences is headquartered in India.
Annual revenue of CureMarkMediSciences is $225.72K as on Mar 31, 2023.
Cure Mark Medisciences Pvt. Ltd. is a pharmaceutical company based in Bengaluru, India, that focuses on creating and distributing a wide range of medicines, including antipyretics, antibiotics, and cardiac drugs. They prioritize innovation, quality, and affordability, serving patients through franchises and hospitals across India and internationally. The company employs a dedicated team of professionals to ensure efficient distribution and meet customer needs effectively.
CureMarkMediSciences's top competitors include Inventia Healthcare, Zim Labs and Lotus.
CureMarkMediSciences offers Antipyretics & Anti-Inflammatory, Anti-Biotic & Antibacterial, Antacid & Anti-Ulcerant, Multivitamin & Hematinics, and Cardiac & Diabetic.